Navigation Links
Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
Date:3/28/2011

rants a waiver in respect of Listing Rule 6.23.2 to permit the cancellation of options pursuant to the Unlisted Option Cancellation Letters; and(bb)

no Unlisted Option Cancellation Letter is terminated or amended and no rights of ChemGenex under any Unlisted Option Cancellation Letter are waived or released by ChemGenex;(I)

no member of the ChemGenex Group discloses the existence of any matter described in Condition (e)(i) or sub-paragraphs (A) to (H) of this Condition (e)(ii), or agrees, offers or authorises, or announces any intention or proposal, to do anything described in Condition (e)(i) or sub-paragraphs (A) to (H) of this Condition (e)(ii); and(J)

there is no announcement or other disclosure, and it does not otherwise become known to Cephalon CXS, that any options or other convertible securities or performance rights were in existence as at the Announcement Date other than Disclosed Options.(f)

Inter-conditionalityThe Option Offer having become or having been declared free of all conditions (other than condition (f) of those conditions).Each of the conditions in each paragraph and sub-paragraph above constitutes and is to be constituted as a separate, several and distinct condition and will not be taken to limit the meaning or effect of any other condition.

Appendix BListed Option Offer ConditionsCephalon CXS's offer for ChemGenex Listed Options is proposed to be subject to the fulfillment of conditions which are the same as the conditions in Appendix A except that Share Offer Conditions (a) and (f) are replaced, respectively, with the following:

(a)

Minimum acceptance conditionBefore and at the end of the Offer Period, Cephalon CXS has a relevant interest in at least 90% of ChemGenex Listed Options.(f)

Inter-conditionalityThe Share Offer having become or having been declared free of all conditions (other than condition (f) of those conditions).This is a non-waivable condition.Appendix CGlos
'/>"/>

SOURCE Cephalon, Inc.; ChemGenex Pharmaceuticals Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Cephalon Wins FENTORA Patent Suit Against Watson
2. Cephalon Announces Definitive Agreement to Acquire Gemin X
3. Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010
4. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
5. ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
6. Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
7. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
8. Cephalon to Webcast Investor Day
9. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
10. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
11. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...  Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical ... virus infections, today announced that Jonathan P. ... of Finance, a newly created role.  Mr. Freve ... including financial planning and reporting, accounting and risk ... , President and CEO. Mr. ...
(Date:2/26/2015)... Israel , Feb. 26, 2015 Integrity ... of the GlucoTrack ® model DF-F, a noninvasive  device ... Lutz Heinemann , Ph.D., will head its new ... opinion leaders in the field of Diabetes research, monitoring ... , Ph.D has been Chief Executive Officer and Head, ...
(Date:2/26/2015)... Feb. 26, 2015 The market for ... is estimated at 2.4 billion in 2014.   ... growth, government insurance, newly insured patients and updated ... and will continue to propel demand.  The healthcare market ... the market and interviews with IVD manufacturers and ...
Breaking Medicine Technology:Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 3Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 4
... Calif., Dec. 12, 2011 Since 1994, the Huntington ... of various specialties, has been providing expert medical care ... accepts almost every major health plan and is affiliated ... HMF is the group,s mission to provide a collaborative ...
... 12, 2011 /PRNewswire-iReach/ -- Thomas Ash was ... Ametros as executive vice president in February 2011. Prior ... compensation managed care industry. He served as vice president ... of national occupational health for Kaiser Permanente, division president ...
Cached Medicine Technology:The Huntington Medical Foundation -- Pasadena's Premier Medical Group 2Ametros Financial Names Thomas Ash as CEO 2
(Date:2/26/2015)... Francisco, CA (PRWEB) February 26, 2015 ... the American College of Traditional Chinese Medicine (ACTCM). ACTCM ... starting off with the Chinese New Year celebration and ... event schedule is as follows: , Sunday, March 1 ... 2:30 p.m., ACTCM celebrates the Chinese New Year with ...
(Date:2/26/2015)... When Cosmetic Town launched in 2012, its ... what will soon be, the cornerstone of work that ... of insight that will be accessible to the public, ... has maintained during its existence. Users have more data ... by visiting the Cosmetic Town Journal’s doctor’s page. There ...
(Date:2/26/2015)... 26, 2015 PartnerTech Inc . has ... Makers Awards finalist. , The Movers & ... in the manufacturing, processing, or distribution of tangible products and ... This annual event serves as Georgia’s largest local awards ... to draw more than 300 local industry and business leaders. ...
(Date:2/26/2015)... 26, 2015 Participants in the ... Working? What’s Not? What’s New? ,” will learn ... to achieve strong outcomes for duals-plan members and ... in the implementation phase of programs for Medicare-Medicaid ... Which ones need to be implemented in the ...
(Date:2/26/2015)... 26, 2015 The hip resurfacing procedure ... and Central Texas resident John Short to resume his active ... set out to climb Mt. Kilimanjaro, the highest free-standing mountain ... trafficking. , Starting in his late 20s, Short suffered from ... hip bones and sockets were bone on bone. , ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces March Schedule of Events 2Health News:Cosmetic Town has now Recreated Itself by Adding New Features 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3Health News:Upcoming AIS Virtual Conference Will Explain What Is and Is Not Working in Medicare-Medicaid Dual Eligibles Programs 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3
... Association (AGA) Research Foundation has announced the 2011 ... Eli and Edythe Broad Foundation, the awards are ... digestive diseases. "At a time of ... are critical for the future of gastroenterology research, ...
... HealthDay Reporter , WEDNESDAY, June 8 (HealthDay News) -- ... the same time they,re having a uterine aspiration due to ... compared to women offered one later on, new research suggests. ... for IUDs inserted immediately after a uterine aspiration is higher ...
... of "pay-for-performance" bonuses to try to reduce racial and ethnic ... no evidence of the problem at any of the state,s ... questions about the effectiveness of the state,s novel approach. ... Health Affairs (June 9, 2011), found that racial and ...
... as an intrauterine device or IUD immediately following a first ... have an unintended pregnancy than those who delay getting an ... Oregon Health & Science University. The findings are ... Medicine . Research has shown that IUDs are safe, ...
... , WEDNESDAY, June 8 (HealthDay News) -- Jogging, ... protect the brain from "silent strokes," or small brain lesions ... of a future stroke, a new study suggests. "These ... they have been associated with an increased risk of falls ...
... of Sheffield have discovered valuable insight into how people ... in the UK. The team, from the University,s ... Lymphoma Research, Biotechnology and Biological Sciences Research Council (BBSRC) ... to that previously thought to be the cause of ...
Cached Medicine News:Health News:Outstanding high school students receive AGA Research Foundation Fellowship Awards 2Health News:It's Safe to Get IUD Right After Abortion, Miscarriage: Study 2Health News:It's Safe to Get IUD Right After Abortion, Miscarriage: Study 3Health News:Pioneering hospital pay-for-performance program falls short of its goals 2Health News:Immediate use of an IUD following abortion more likely to prevent unintended pregnancies 2Health News:Exercise May Protect the Brain From 'Silent Strokes' 2Health News:New research provides breakthrough in understanding common cancer 2
... FlexSure HP is a visually read, qualitative ... to H. pylori, a bacterium that grows ... peptic ulcer disease and some gastric cancers. ... whole blood or serum samples, provides the ...
Rapid Infectious Mononucleosis Heterophile Antibody (IgM) Test...
Unitary one step immuno-chromatographic assay for the qualitative detection of infectious mononucleosis heterophile antibodies in human serum, plasma or whole blood....
A simple, in-office test for the detection of mononucleosis. Easy to use with fast, accurate results within minutes....
Medicine Products: